NKTR
Nektar Therapeutics
40.80$
+1.3%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | 9.9 | 14.1 | 8.4 | 8.9 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 14.1 | 11.1 | 27.5 | 22.9 | 15.6 | 30.7 | 53.3 | 6.5 | 8.4 | 4.8 | 4.9 | 52.2 | 26.5 | 33.2 | 23.2 | 25.5 | 18.2 | 20.0 | 28.8 | 29.8 | 33.0 | 24.5 | 9.7 | 7.4 | 6.3 | 4.7 | 1.5 | 1.2 | 1.3 | 1.2 | 2.0 | 2.7 | 2.9 | 2.0 | 1.6 | 4.9 | 12.8 | 15.5 | 32.0 | 42.3 | |
| – | 20.8 | 80.7 | 899.3 | 46.4 | 107.6 | 293.4 | 4.8 | 5.9 | 3.3 | 3.6 | 4.0 | 2.1 | 2.7 | 2.4 | 3.3 | 2.5 | 2.8 | 3.6 | 3.5 | 4.1 | 3.7 | 1.7 | 1.5 | 1.5 | 1.2 | 0.6 | 0.6 | 0.7 | 0.8 | 1.4 | 3.1 | 5.6 | 3.3 | 10.4 | – | 9.4 | 9.6 | 3.1 | 2.6 | |
| 15.2 | 12.2 | 29.2 | 24.6 | 16.5 | 31.6 | 54.1 | 6.0 | 8.5 | 4.9 | 5.1 | 53.6 | 28.0 | 34.7 | 23.5 | 25.2 | 18.0 | 18.8 | 27.7 | 28.5 | 32.7 | 24.4 | 9.3 | 6.8 | 5.4 | 3.9 | 0.8 | 0.9 | 0.8 | 1.0 | 1.7 | 2.8 | 2.8 | 1.8 | 1.4 | 4.6 | 12.5 | 15.6 | 30.0 | 42.0 | |
| – | – | – | – | – | – | – | 8.6 | 13.3 | 7.9 | 8.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | 9.7 | 14.1 | 8.1 | 8.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -6.2% | -6.7% | -3.8% | -6.0% | -1.6% | -1.0% | -0.6% | 10.3% | 7.1% | 12.3% | 11.5% | -5.7% | -11.0% | -9.3% | -11.0% | -8.9% | -11.7% | -10.5% | -8.9% | -10.2% | -11.2% | -17.1% | -43.9% | -60.6% | -68.1% | -71.5% | -202.9% | -224.9% | -180.2% | -179.2% | -104.0% | -70.0% | -65.4% | -89.2% | -124.2% | -51.2% | -23.7% | -24.3% | -11.5% | -10.1% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 80.9% | 81.7% | 79.1% | 78.4% | 89.0% | 90.1% | 90.3% | 98.0% | 97.9% | 98.0% | 98.0% | 80.9% | 81.1% | 81.4% | 85.6% | 87.4% | 87.1% | 87.3% | 83.0% | 77.9% | 77.0% | 75.6% | 76.3% | 77.3% | 77.3% | 76.5% | 73.7% | 71.2% | 62.9% | 62.5% | 60.9% | 59.2% | 67.8% | 68.8% | 74.6% | 83.4% | 86.9% | 99.6% | 99.4% | 99.4% | |
| -65.8% | -68.2% | -120.2% | -127.8% | -27.1% | -19.4% | -28.6% | 67.8% | 61.2% | 57.6% | 55.3% | -361.5% | -357.2% | -383.9% | -297.7% | -230.5% | -232.0% | -248.5% | -318.2% | -410.9% | -442.3% | -437.8% | -438.3% | -403.1% | -328.5% | -261.0% | -292.5% | -300.5% | -307.1% | -292.6% | -182.3% | -175.6% | -164.3% | -106.9% | -131.0% | -134.5% | -156.5% | -237.9% | -224.9% | -240.4% | |
| -98.9% | -92.8% | -150.7% | -157.1% | -42.1% | -31.4% | -40.1% | 65.7% | 59.7% | 57.1% | 55.6% | -354.9% | -352.8% | -383.4% | -335.5% | -264.4% | -269.1% | -290.6% | -340.3% | -449.7% | -493.6% | -514.0% | -476.6% | -544.8% | -477.9% | -400.0% | -467.0% | -349.8% | -332.7% | -306.3% | -195.0% | -190.1% | -180.7% | -120.9% | -152.5% | -163.2% | -192.9% | -297.1% | -284.2% | -287.8% | |
| -87.2% | -74.6% | -104.2% | -137.0% | -25.0% | -29.3% | -32.7% | 66.4% | 59.8% | 59.0% | 56.7% | -295.1% | -292.2% | -309.7% | -253.6% | -226.7% | -213.7% | -209.6% | -255.2% | -304.5% | -369.3% | -419.6% | -427.2% | -446.3% | -430.2% | -336.4% | -303.3% | -279.6% | -231.6% | -214.7% | -209.8% | -188.3% | -190.9% | -180.0% | -204.2% | -248.3% | -304.1% | -377.8% | -366.6% | -428.7% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| – | -174.2% | -442.2% | -6,177.2% | -124.8% | -110.1% | -220.7% | 48.5% | 41.7% | 39.7% | 40.3% | -27.2% | -28.6% | -31.3% | -35.4% | -34.2% | -37.5% | -41.3% | -43.1% | -52.4% | -61.8% | -77.1% | -80.8% | -114.4% | -110.2% | -100.4% | -172.2% | -155.8% | -184.3% | -210.8% | -138.8% | -222.2% | -344.3% | -195.9% | -968.4% | – | -141.9% | -182.6% | -27.4% | -17.4% | |
| -38.9% | -27.0% | -37.4% | -44.0% | -18.1% | -19.0% | -25.9% | 39.0% | 33.2% | 31.7% | 30.4% | -20.1% | -20.4% | -22.2% | -24.3% | -26.9% | -29.1% | -28.9% | -29.4% | -34.6% | -38.8% | -46.9% | -48.0% | -60.9% | -58.2% | -51.8% | -73.8% | -62.1% | -66.4% | -69.4% | -44.4% | -51.6% | -54.6% | -39.2% | -51.9% | -58.9% | -40.1% | -58.5% | -20.7% | -14.3% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 184 | 190 | 226 | 234 | 212 | 272 | 261 | -607 | 103 | 114 | 144 | 170 | 186 | 169 | 43 | -43 | -40 | -185 | -134 | -136 | -36 | -7.8 | -48 | -57 | -87 | -70 | -58 | -32 | -46 | -16 | -29 | 7.4 | -8.6 | -24 | -17 | -21 | -19 | 5.4 | -109 | -16 | |
| – | – | – | – | – | – | – | -0.6 | 0.1 | 0.2 | 0.2 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -16.0% | 15.5% | 8.5% | 0.7% | 14.5% | 17.3% | 11.7% | 80.4% | 79.6% | 79.9% | 75.4% | 74.2% | 71.3% | 71.1% | 68.7% | 78.8% | 77.6% | 70.0% | 68.3% | 66.0% | 62.8% | 60.8% | 59.4% | 53.2% | 52.8% | 51.6% | 42.9% | 39.8% | 36.0% | 32.9% | 32.0% | 23.2% | 15.9% | 20.0% | 5.4% | -11.7% | 28.2% | 32.0% | 75.5% | 82.5% | |
| – | 2.8 | 5.6 | 73.8 | 3.0 | 3.2 | 5.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.4 | 0.3 | 1.6 | – | 0.3 | 0.2 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -18.10 | -15.45 | -19.32 | -20.20 | -9.69 | -9.16 | -11.99 | 74.28 | 64.77 | 58.98 | 56.82 | -36.33 | -36.38 | -37.42 | -38.90 | -36.14 | -36.80 | -37.10 | -35.46 | -38.94 | -40.36 | -42.48 | -39.65 | -42.14 | -36.31 | -29.34 | -32.94 | -24.27 | -23.13 | -21.68 | -13.54 | -12.72 | -12.06 | -8.35 | -9.46 | -8.68 | -8.57 | -8.08 | -6.39 | -4.75 | |
| 18.31 | 16.65 | 12.82 | 12.85 | 23.03 | 29.15 | 29.93 | 113.07 | 108.48 | 103.31 | 102.11 | 10.24 | 10.31 | 9.76 | 11.60 | 13.67 | 13.68 | 12.77 | 10.42 | 8.66 | 8.18 | 8.26 | 8.32 | 7.74 | 7.60 | 7.34 | 7.05 | 6.94 | 6.95 | 7.08 | 6.94 | 6.69 | 6.68 | 6.91 | 6.20 | 5.32 | 4.44 | 2.72 | 2.25 | 1.65 | |
| -7.42 | 8.87 | 4.37 | 0.33 | 7.76 | 8.32 | 5.43 | 153.09 | 155.48 | 148.69 | 140.93 | 133.82 | 127.31 | 119.69 | 109.75 | 105.67 | 98.08 | 89.93 | 82.25 | 74.30 | 65.30 | 55.11 | 49.06 | 36.84 | 32.95 | 29.22 | 19.13 | 15.58 | 12.55 | 10.28 | 9.76 | 5.72 | 3.50 | 4.27 | 0.98 | -1.72 | 6.04 | 4.43 | 23.29 | 27.32 | |
| -15.97 | -12.42 | -13.35 | -17.61 | -5.75 | -8.54 | -9.78 | 75.11 | 64.92 | 60.94 | 57.88 | -30.21 | -30.13 | -30.23 | -29.41 | -30.99 | -29.24 | -26.76 | -26.59 | -26.36 | -30.19 | -34.68 | -35.54 | -34.52 | -32.69 | -24.68 | -21.40 | -19.40 | -16.10 | -15.19 | -14.57 | -12.60 | -12.75 | -12.44 | -12.67 | -13.21 | -13.51 | -10.28 | -8.24 | -7.08 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.